Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000721773 | SCV000852910 | likely pathogenic | not provided | 2016-08-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001049222 | SCV001213263 | pathogenic | Cerebral cavernous malformation 2 | 2022-07-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 590650). This variant has not been reported in the literature in individuals affected with CCM2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg57*) in the CCM2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CCM2 are known to be pathogenic (PMID: 18300272, 24689081). |
Revvity Omics, |
RCV001049222 | SCV003820518 | likely pathogenic | Cerebral cavernous malformation 2 | 2023-01-19 | criteria provided, single submitter | clinical testing |